Timothy E Schultheiss
Overview
Explore the profile of Timothy E Schultheiss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schultheiss T
Int J Radiat Oncol Biol Phys
. 2021 May;
110(2):609.
PMID: 33989579
No abstract available.
2.
Christodouleas J, Hall M, van der Pas M, Guo W, Schultheiss T, Gabriel P
Radiat Oncol
. 2017 Jan;
12(1):19.
PMID: 28095882
Purpose/objectives: The clinical effects of radiation dose-intensification in locally advanced non-small cell lung (NSCLCa) and other cancers are challenging to predict and are ideally studied in randomized trials. The purpose...
3.
Han C, Schultheiss T, Wong J
Pract Radiat Oncol
. 2017 Jan;
7(3):e185-e194.
PMID: 28089479
Purpose: In this study, we evaluated radiation-induced secondary lung cancer risks for the lung and the breast from stereotactic body radiation therapy treatment of early-stage non-small cell lung cancer with...
4.
Hall M, Schultheiss T, Smith D, Fakih M, Wong J, Chen Y
Acta Oncol
. 2016 Oct;
55(12):1392-1399.
PMID: 27762654
Background: Neoadjuvant chemoradiation therapy (CRT) increases pathological complete response (pCR) rates compared to radiotherapy alone in patients with stage II-III rectal cancer. Limited evidence addresses whether radiotherapy dose escalation further...
5.
Cahan B, Kim J, Schultheiss T, Wong J, Chen Y
Am J Clin Oncol
. 2016 Feb;
41(3):302-306.
PMID: 26886945
Background: In 2009, the International Federation of Gynecology and Obstetrics revised the staging classification for endometrial cancer. Mucosal cervical involvement was eliminated from the criteria and only those with stromal...
6.
Sampath S, Hall M, Schultheiss T
Lung Cancer
. 2015 Aug;
90(1):61-4.
PMID: 26231092
Objectives: There is a paucity of data on non-surgical outcomes specific to stage II non-small cell lung cancer (NSCLC) patients receiving definitive chemotherapy and radiation therapy (CRT). This study reports...
7.
Hall M, Schultheiss T, Smith D, Tseng B, Wong J
Radiat Oncol
. 2015 May;
10:115.
PMID: 25990489
Purpose: To assess the impact of increasing dose on overall survival (OS) for prostate cancer patients. Methods: Treatment data were obtained on more than 20,000 patients in the National Oncology...
8.
Hall M, Schultheiss T, Smith D, Fakih M, Kim J, Wong J, et al.
Ann Surg Oncol
. 2015 May;
22 Suppl 3:S580-7.
PMID: 25956577
Purpose: Current guidelines recommend that a minimum of 12 lymph nodes (LNs) be dissected to accurately stage rectal cancer patients. Neoadjuvant chemoradiation therapy (CRT) decreases the number of LNs retrieved...
9.
Liu A, Vora N, Suh S, Liu A, Schultheiss T, Wong J
Med Dosim
. 2014 Sep;
40(1):32-6.
PMID: 25242679
The objectives of the study were to evaluate the effect of intravenous contrast in the dosimetry of helical tomotherapy and RapidArc treatment for head and neck cancer and determine if...
10.
Hall M, Schultheiss T, Smith D, Nguyen K, Wong J
Int J Radiat Oncol Biol Phys
. 2014 Sep;
91(1):22-9.
PMID: 25227496
Purpose/objective(s): To perform a meta-regression on published data and to model the 5-year probability of cataract development after hematopoietic stem cell transplantation (HSCT) with and without total body irradiation (TBI)....